Find out why Nurofen for Children is a first-line choice for pain and fever relief in children1,2
Nurofen is a first-line choice for pain and fever in children,1,2 with a fast onset from 15 minutes and a duration of action of up to 8 hours.3,4 However, its utilisation may be limited by common myths about its safety and tolerability profile.5,6 Published evidence suggests that this needn’t be the case.4,7,8
It is often thought that Nurofen for Children is harsh on little tummies.5,6 However in reality, Nurofen for Children has the same low risk of side effects as paracetamol when taken as directed, including gastrointestinal and respiratory.4,7,8 Plus, Nurofen for Children acts fast to reduce a fever from 15 minutes.3
Some people believe that Nurofen for Children is not a suitable first-line choice for everyday pain and fever.5,6 However in reality, Nurofen for Children can be used first-line for everyday pain and fever including for toothache, earache and sprains or strains.1,2 Plus, it provides up to 8 hours of relief from fever, so kids can get back to what they do best.4
Did you know that taking Nurofen for Children with food could affect how it works?8,10 However, taking it without food may result in faster absorption, and generally faster pain relief than taking it with food.8,10 So when fever strikes, bring it down fast with Nurofen for Children.3
Separate myth from fact, and get to know your Nurofen for Children.
Nurofen for Children contains ibuprofen. For the temporary relief of pain and/or fever in children 3 months to 12 years of age.
References: 1. NSW Government. Children and Infants with Fever – Acute Management. Available at http://www1.health.nsw.gov.au/pds/ActivePDSDocuments/PD2010_063.pdf. Accessed May 2017. 2. NSW Government. Infants and Children: Management of Acute and Procedural Pain in the Emergency Department. Available at http://www1.health.nsw.gov.au/pds/ActivePDSDocuments/GL2016_009.pdf. Accessed May 2017. 3. Pelen F et al. Ann Pediatr 1998; 45(10): 719–28. 4. Autret-Leca E et al. Curr Med Res Opin 2007; 23(9): 2205–11. 5. IPSOS Usage & Attitude Survey; Australia, 2010. 6. Quintiles IMS Brand Health Tracker 2016, W2. 7. Southey ER et al. Curr Med Res Opin 2009; 25(9): 2207–22. 8. Kanabar DJ. Inflammopharmacol 2017;25:1–9. 9. IMS Health, Brand Health Tracker, 2016. 10. Rainsford KD et al. J Pharm Pharmacol 2012;64:465–9.
®NUROFEN is a registered trademark of Reckitt Benckiser (Australia) Pty Ltd. Level 47, 680 George St, Sydney 2000, NSW Australia. Prepared July 2017. NUR0332e.